Latest news
Stifel Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $40 - MoomooMoomoo · Fri, 07 Aug 2026 20:33:34 GMTOculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 02:35:00 GMTOculis Holding AG reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 01:55:00 GMTOculis Q2 2026 Results: Finance Gains Narrow the Net Loss - TradingKeyTradingKey · Fri, 07 Aug 2026 01:13:02 GMTOculis Q2 2026 Results: Finance Gains Narrow the Net Loss Despite Higher Costs - TradingKeyTradingKey · Thu, 06 Aug 2026 21:01:43 GMTOculis (NASDAQ: OCS) pivots to neuro-ophthalmology as H1 loss falls - Stock TitanStock Titan · Thu, 06 Aug 2026 20:17:00 GMTOculis Reports Q2 2026 Financial Results and Provides Company Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTOculis Holding AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 20:05:00 GMT